D
Diego Albani
Researcher at Mario Negri Institute for Pharmacological Research
Publications - 190
Citations - 13004
Diego Albani is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Bipolar disorder & Population. The author has an hindex of 35, co-authored 178 publications receiving 10355 citations. Previous affiliations of Diego Albani include National Research Council.
Papers
More filters
Posted ContentDOI
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
Giuseppe Fanelli,Giuseppe Fanelli,Katharina Domschke,Alessandra Minelli,Massimo Gennarelli,Paolo Martini,Marco Bortolomasi,Eduard Maron,Eduard Maron,Alessio Squassina,Siegfried Kasper,Joseph Zohar,Daniel Souery,Stuart Montgomery,Diego Albani,Gianluigi Forloni,Panagiotis Ferentinos,Dan Rujescu,Julien Mendlewicz,Diana De Ronchi,Bernhard T. Baune,Bernhard T. Baune,Bernhard T. Baune,Alessandro Serretti,Chiara Fabbri,Chiara Fabbri +25 more
TL;DR: Although PRSs are still not able to predict non-response or non-remission, the results are in line with previous works; methodological improvements inPRSs calculation may improve their predictive performance and have a meaningful role in precision psychiatry.
Journal ArticleDOI
The microbiota‐gut‐brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models
Federica Fusco,Simone Perottoni,Carmen Giordano,Antonella Riva,Luigi Francesco Iannone,Carmen De Caro,Emilio Russo,Diego Albani,Pasquale Striano +8 more
TL;DR: The evidence of a role of the MGB axis in epilepsy is summarized by providing an overview of the recent clinical and preclinical studies and showing how dietary modification, microbiome supplementations, and hence, microbiota alterations may have an impact on seizures.
Multiplex assessment of a panel of 16 serum molecules for the differential diagnosis of Alzheimer's disease.
Gloria Biella,Massimo Franceschi,Francesca de Rino,Annalisa Davin,Giacomo Giacalone,Paola Brambilla,Panagiotis Bountris,Maria Haritou,Giuseppe Magnani,Filippo Martinelli Boneschi,Gianluigi Forloni,Diego Albani +11 more
TL;DR: A multiplex fluorimetric assay comprising 16 independent analytes and covering 15 out of the 18 described proteins found an increased level of EGF-1 in AD in comparison to CNT and NAD, while an increase of TRAIL-R4 was found in NAD.
Journal ArticleDOI
Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and Aβ1-42-mediated toxicity.
Debasmita Tripathy,Alice Migazzi,Federica Costa,Alessandro Roncador,Pamela Gatto,Federica Fusco,Lucia Boeri,Diego Albani,J Leon Juárez-Hernández,Carlo Musio,Laura Colombo,Mario Salmona,Micha M.M. Wilhelmus,Benjamin Drukarch,Maria Pennuto,Manuela Basso +15 more
TL;DR: In this paper, the involvement of transglutaminase 1 (TG1) in in vitro AD models of neuronal toxicity was reported, which indicated that TG1 acts downstream of Aβ-toxicity and that its stress-dependent increase makes it suitable for pharmacological intervention.
Journal ArticleDOI
Genetic variants associated with psychotic symptoms across psychiatric disorders.
Marco Calabrò,Stefano Porcelli,Concetta Crisafulli,Diego Albani,Siegfried Kasper,Joseph Zohar,Daniel Souery,Stuart Montgomery,Vilma Mantovani,Julien Mendlewicz,Stefano Bonassi,Eduard Vieta,Alessandra Frustaci,Giuseppe Ducci,Stefano Landi,Stefania Boccia,Antonello Bellomo,Marco Di Nicola,Luigi Janiri,Roberto Colombo,Francesco Benedetti,Laura Mandelli,Chiara Fabbri,Alessandro Serretti +23 more
TL;DR: The findings confirmed that deep phenotyping is pivotal to clarify the role of genetic variants on symptoms patterns, and was associated with psychotic symptoms independently from the diagnosis, in line with the evidence of a cross disorder effect of many risk variants.